DOCSLIB.ORG

Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting Published OnlineFirst August 19, 2014; DOI: 10.1158/1541-7786.MCR-14-0118 Signal Transduction Molecular Cancer Research Annexin 2–CXCL12 Interactions Regulate Metastatic Cell Targeting and Growth in the Bone Marrow Younghun Jung1, Jingcheng Wang1, Eunsohl Lee1, Samantha McGee1, Janice E. Berry1, Kenji Yumoto1, Jinlu Dai2, Evan T. Keller2, Yusuke Shiozawa1, and Russell S. Taichman1 Abstract Anxa2þ þ Anxa2À À Annexin 2 (ANXA2) plays a critical role in hematopoietic stem BMSC / or BMSC / . Significantly larger tumors grew Anxa2þ þ cell (HSC) localization to the marrow niche. In part, ANXA2 in the mice when the tumors were established with BMSC / Anxa2À À supports HSCs by serving as an anchor for stromal-derived factor- compared with the tumors established with BMSC / .In 1 (CXCL12/SDF-1). Recently, it was demonstrated that prostate addition, fewer prostate cancer cells underwent apoptosis when Anxa2þ þ Anxa2À À cancer cells, like HSCs, use ANXA2 to establish metastases cocultured with BMSC / compared with BMSC / , in marrow. The present study determined the capacity of and similar results were obtained in tumors grown in vivo. Finally, ANXA2 expression by bone marrow stromal cells (BMSC) to significantly more vascular structures were observed in the tumors Anxa2þ þ facilitate tumor recruitment and growth through ANXA2– established with the BMSC / compared with the tumors Anxa2À À CXCL12 interactions. Significantly more CXCL12 was expressed established with BMSC / . Thus, ANXA2–CXCL12 interac- Anxa2þ þ Anxa2À À by BMSC / than by BMSC / resulting in more pros- tions play a crucial role in the recruitment, growth, and survival of Anxa2þ þ tate cancer cells migrating and binding to BMSC / than prostate cancer cells in the marrow. Anxa2À À BMSC / , and these activities were reduced when CXCL12 interactions were blocked. To further confirm that BMSC Implications: The tumor microenvironment interaction between signaling through ANXA2–CXCL12 plays a critical role in tumor ANXA2–CXCL12 is critical for metastatic phenotypes and may growth, immunocompromised SCID mice were subcutaneously impact chemotherapeutic potential. Mol Cancer Res; 13(1); 197–207. implanted with human prostate cancer cells mixed with Ó2014 AACR. Introduction osteoclasts, osteomacs, and endothelial cells aid in the develop- ment and organization of the HSC niche (7–9). Prostate cancer is the second leading cause of cancer deaths in Bone marrow stromal cells (BMSC) are a heterogeneous pop- American males (1, 2). The high mortality rate is due mainly to the ulation of cells, which also are known to contribute to the spread of malignant cells to many tissues including bone (3, 4). At generation of the HSC niche. There is growing evidence that a the single cell level, the multistep process of metastasis is very subpopulation of BMSCs has progenitor and/or stem-like activ- inefficient, where less than 2% of disseminated tumor cells ities that are capable of locally generating multiple connective (DTC) are estimated to form micrometastasis and fewer still tissue lineages under conditions of stress or wound repair (e.g., (0.02%) develop into macrometastasis (5). In part, a barrier endothelial, adipocytic, osteoblastic, cartilage, and muscle cells; for DTCs to form clinically relevant metastases is not only the ref. 7–9). Although still controversial, if BMSCs are mobilized ability to survive in the circulation during dissemination but also or injected into the circulation, BMSCs may participate in tissue the ability to home to and engage in a safe environment, which repair at distant organs (9). In the context of tumors, when can immediately support their survival. We recently reported that BMSCs are localized in tumor beds, cytokine cross-talk leads to DTCs target and engage the hematopoietic stem cell (HSC) niche the emergence of an increasingly aggressive tumor phenotype to establish metastases in marrow (6). While the nature and the (10–17). components of the HSC niche remain controversial, significant Two important signal transducers in the bone marrow niche are evidence suggests that cells of the osteoblastic lineage, adipocytes, stromal-derived factor-1 (SDF-1 or CXCL12; refs. 18–29) and annexin 2 (ANXA2; ref. 30). CXCL12 is a central regulator of HSC homing and recruitment into marrow and HSC mobilization into 1Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan. 2Department of Urology and the circulation. Indeed, blockage of CXCL12 or its receptor pre- Pathology, University of Michigan School of Medicine, Ann Arbor, vents HSC homing or mobilizes niche-bound HSC into the Michigan. circulation (18–24). ANXA2, on the other hand, likely serves as Corresponding Author: Russell S. Taichman, Department of Periodontics and an adhesion molecule, facilitating HSC binding to the osteoblas- Oral Medicine, University of Michigan School of Dentistry, 1011 North University tic niche (25). Critically, it has been shown that CXCL12 and Avenue, Ann Arbor, MI 48109. Phone: 1-734-764-9952; Fax: 1-734-763-5503; ANXA2 directly bind to one another, and this interaction facil- E-mail: [email protected] itates hematopoietic progenitor cell migration in response to doi: 10.1158/1541-7786.MCR-14-0118 CXCL12 (26). In fact, loss of ANXA2 is associated with decreased Ó2014 American Association for Cancer Research. levels of CXCL12 in marrow. Likewise, CXCL12 and ANXA2 play www.aacrjournals.org 197 Downloaded from mcr.aacrjournals.org on September 30, 2021. © 2015 American Association for Cancer Research. Published OnlineFirst August 19, 2014; DOI: 10.1158/1541-7786.MCR-14-0118 Jung et al. similar roles in recruiting and localizing tumor cells into the HSC were labeled with 2.5 mg/mL of the lipophilic dye carboxyfluor- niche (27–30). escein diacetate (CFDA, cat. V12883; Molecular Probes) in RPMI In the present study, we explored whether ANXA2 facilitates for 30 minutes at 37C and washed in PBS. Thereafter, prostate metastasis and growth of prostate cancer through its interactions cancer cells (1 Â 104 cells per well) were added to each well and with CXCL12. We demonstrate that ANXA2-expressing BMSCs were left for 30 minutes at room temperature to allow binding to express more CXCL12 than do ANXA2-deficient BMSCs, and the BMSCs. In some cases, adhesion assays of prostate cancer cells to production of these 2 proteins increases the recruitment of pros- BMSCs were done in the presence or absence of function blocking tate cancer cells into the marrow niche. In addition, CXCL12 antibody to ANXA2 (cat. 610069; BD Pharmingen), with matched produced by ANXA2-expressing BMSCs promotes prostate cancer IgG as an antibody control. Total fluorescence per well was proliferation, protects prostate cancer from chemotherapy- determined initially, followed by washing wells with PBS to induced apoptosis, and increases the development of vascular quantify fluorescence for prostate cancer cells adherent to BMSCs. structures. Our results suggest that ANXA2 and CXCL12 interac- tions facilitate the recruitment, growth, and survival of prostate Transwell chemotaxis assay Anxa2þ þ Anxa2À À cancer cells in marrow. BMSC / or BMSC / (1 Â 105 cells per well) were seeded onto 24-well culture plates. Prostate cancer cells or Materials and Methods HBMECs were labeled with 2.5 mg/mL of CFDA as described Cell culture above. Prostate cancer cells or HBMECs were resuspended in The human prostate cancer cell line PC3 was obtained from the serum-free RPMI-1640 and equilibrated for 10 minutes at 37 C. ATCC. C4-2B, the metastatic subline of the prostate cancer cell line CFDA-labeled prostate cancer cells or HBMECs were loaded into LNCaP, was originally isolated from a lymph node of a patient the top chambers of 8-mm Transwell microporous membrane 24- with disseminated bony and lymph node involvement. Lucifer- well plates (cat. 3422; Costar Corp.). A total of 650 mLof Luc Luc ase-expressing prostate cancer cell lines (PC3 and C4-2B conditioned medium (CM) from 3-day cultures of GFP Anxa2þ/þ Anxa2À/À 5 cells) and GFP-expressing prostate cancer cell lines (PC3 and BMSC or BMSC (1 Â 10 cells per well) was GFP C4-2B cells) were established by lentiviral transduction. added into the bottom well. The plates were incubated at 37 C Human bone marrow endothelial cells (HBMEC) were isolated for 3 hours. At the termination of the experiments, the intensity of from a normal Caucasian male and immortalized with SV40 large fluorescence in the lower chamber, indicating the number of cells T-antigen (31). Prostate cancer cells and HBMEC were grown in that had migrated, was determined by plate reader (Molecular RPMI-1640 (Invitrogen) supplemented with 10% FBS and 1% Probes). In some cases, migration of prostate cancer cells to CM penicillin/streptomycin (P/S). isolated from BMSCs was analyzed in the presence of neutralizing þ þ À À BMSCs from Anxa2 / or Anxa2 / mice (5- to 7-week-old) anti-CXCL12 monoclonal antibodies (120 mg/mL, cat. MAB310; were used for this study. Dr. K.A. Hajjar (Weill Medical College of R&D Systems) or AMD3100, a selective CXCR4 antagonist (4 ng/ Cornell University, New York, NY) graciously provided our lab- mL, cat. A5602; Sigma). À À oratory with a pair of the homozygous Anxa2 / mice for breed- ing (32). After sacrifice, marrow was flushed from femurs and Cell death assay þ/þ À/À Anxa2þ þ Anxa2À À tibias of both Anxa2 and Anxa2 mice with a-MEM (Invi- BMSC / or BMSC / (1 Â 105 cells per well) were trogen) containing 2% FBS and cultured in a-MEM containing seeded onto 12-well culture plates for 24 hours. GFP-expressing 15% heat-inactivated FBS and 1% P/S to generate primary BMSCs. prostate cancer cells (1 Â 105 cells per well) were added to the Once confluent, the cells were passaged 2 to 3 times with trypsin to wells and cultured together with the BMSCs for 48 hours before minimize macrophage contamination.
Load more

Recommended publications
  • Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle
    International Journal of Molecular Sciences Review Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle Toshihisa Komori Basic and Translational Research Center for Hard Tissue Disease, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan; [email protected]; Tel.: +81-95-819-7637; Fax: +81-95-819-7638 Received: 17 September 2020; Accepted: 10 October 2020; Published: 12 October 2020 Abstract: Osteocalcin (Ocn), which is specifically produced by osteoblasts, and is the most abundant non-collagenous protein in bone, was demonstrated to inhibit bone formation and function as a hormone, which regulates glucose metabolism in the pancreas, testosterone synthesis in the testis, / / and muscle mass, based on the phenotype of Ocn− − mice by Karsenty’s group. Recently, Ocn− − mice were newly generated by two groups independently. Bone strength is determined by bone / quantity and quality. The new Ocn− − mice revealed that Ocn is not involved in the regulation of bone formation and bone quantity, but that Ocn regulates bone quality by aligning biological apatite (BAp) parallel to the collagen fibrils. Moreover, glucose metabolism, testosterone synthesis and / spermatogenesis, and muscle mass were normal in the new Ocn− − mice. Thus, the function of Ocn is the adjustment of growth orientation of BAp parallel to the collagen fibrils, which is important for bone strength to the loading direction of the long bone. However, Ocn does not play a role as a hormone in the pancreas, testis, and muscle. Clinically, serum Ocn is a marker for bone formation, and exercise increases bone formation and improves glucose metabolism, making a connection between Ocn and glucose metabolism.
    [Show full text]
  • Osteocalcin Improves Outcome After Acute Ischemic Stroke
    www.aging-us.com AGING 2020, Vol. 12, No. 1 Research Paper Osteocalcin improves outcome after acute ischemic stroke Jiayan Wu1, Yunxiao Dou1, Wangmi Liu2, Yanxin Zhao1, Xueyuan Liu1 1Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200032, China 2The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China Correspondence to: Xueyuan Liu, Yanxin Zhao, Wangmi Liu; email: [email protected], [email protected], [email protected] Keywords: osteocalcin, acute ischemic stroke, NIHSS score, proline hydroxylase 1, pyroptosis Received: November 6, 2019 Accepted: December 18, 2019 Published: January 5, 2020 Copyright: Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Background: Osteocalcin is related to energy metabolism, memory and the acute stress response, suggesting a relationship between bone and the brain. The need to explore the effect of osteocalcin on acute ischemic stroke is therefore urgent. Results: Patients with better outcomes had higher serum osteocalcin levels than those whose NIHSS scores did not improve. Multivariable logistic regression analysis showed acceptable performance (area under the curve = 0.766). The effect of osteocalcin on the promotion of neuron survival was confirmed by Cell Counting Kit-8 experiments. In addition, osteocalcin could decrease proline hydroxylase 1 and inhibit the degradation of gasdermin D. Conclusions: We propose that osteocalcin can improve outcome after acute ischemic stroke in the acute period. By downregulating proline hydroxylase 1, osteocalcin leads glucose metabolism to the pentose phosphate pathway and therefore promotes neuronal survival through inhibiting pyroptosis.
    [Show full text]
  • Expression of Vascular Endothelial Growth Factor in Cultured Human Dental Follicle Cells and Its Biological Roles1
    Acta Pharmacol Sin 2007 Jul; 28 (7): 985–993 Full-length article Expression of vascular endothelial growth factor in cultured human dental follicle cells and its biological roles1 Xue-peng CHEN2, Hong QIAN2, Jun-jie WU2, Xian-wei MA3, Ze-xu GU2, Hai-yan SUN4, Yin-zhong DUAN2,5, Zuo-lin JIN2,5 2Department of Orthodontics, Qindu Stomatological College, Fourth Military Medical University, Xi’an 710032, China; 3Institute of Immunology, Second Military Medical University, Shanghai 200433, China; 4Number 307 Hospital of Chinese People’s Liberation Army, Beijing 100101, China Key words Abstract vascular endothelial growth factor; human Aim: To investigate the expression of vascular endothelial growth factor (VEGF) dental follicle cell; proliferation; differentia- in cultured human dental follicle cells (HDFC), and to examine the roles of VEGF in tion; apoptosis; tooth eruption; mitogen- activated protein kinase the proliferation, differentiation, and apoptosis of HDFC in vitro. Methods: Immunocytochemistry, ELISA, and RT-PCR were used to detect the expression 1 and transcription of VEGF in cultured HDFC. The dose-dependent and the time- Project supported by the National Natural Science Foundation of China (No 30400510). course effect of VEGF on cell proliferation and alkaline phosphatase (ALP) activ- 5 Correspondence to Dr Zuo-lin JIN and Prof ity in cultured HDFC were determined by MTT assay and colorimetric ALP assay, Yin-zhong DUAN. respectively. The effect of specific mitogen-activated protein kinase (MAPK) Phn 86-29-8477-6136. Fax 86-29-8322-3047. inhibitors (PD98059 and U0126) on the VEGF-mediated HDFC proliferation was E-mail [email protected] (Zuo-lin JIN) also determined by MTT assay.
    [Show full text]
  • Osteoblast-Derived Vesicle Protein Content Is Temporally Regulated
    University of Birmingham Osteoblast-derived vesicle protein content is temporally regulated during osteogenesis Davies, Owen G.; Cox, Sophie C.; Azoidis, Ioannis; McGuinness, Adam J.; Cooke, Megan; Heaney, Liam M.; Grover, Liam M. DOI: 10.3389/fbioe.2019.00092 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Davies, OG, Cox, SC, Azoidis, I, McGuinness, AJ, Cooke, M, Heaney, LM & Grover, LM 2019, 'Osteoblast- derived vesicle protein content is temporally regulated during osteogenesis: Implications for regenerative therapies', Frontiers in Bioengineering and Biotechnology, vol. 7, no. APR, 92. https://doi.org/10.3389/fbioe.2019.00092 Link to publication on Research at Birmingham portal Publisher Rights Statement: © 2019 Davies, Cox, Azoidis, McGuinness, Cooke, Heaney and Grover. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication.
    [Show full text]
  • The Products of Bone Resorption and Their Roles in Metabolism: Lessons from the Study of Burns
    Concept Paper The Products of Bone Resorption and Their Roles in Metabolism: Lessons from the Study of Burns Gordon L. Klein Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston, TX 77555-0165, USA; [email protected] Abstract: Surprisingly little is known about the factors released from bone during resorption and the metabolic roles they play. This paper describes what we have learned about factors released from bone, mainly through the study of burn injuries, and what roles they play in post-burn metabolism. From these studies, we know that calcium, phosphorus, and magnesium, along with transforming growth factor (TGF)-β, are released from bone following resorption. Additionally, studies in mice from Karsenty’s laboratory have indicated that undercarboxylated osteocalcin is also released from bone during resorption. Questions arising from these observations are discussed as well as a variety of potential conditions in which release of these factors could play a significant role in the pathophysiology of the conditions. Therapeutic implications of understanding the metabolic roles of these and as yet other unidentified factors are also raised. While much remains unknown, that which has been observed provides a glimpse of the potential importance of this area of study. Keywords: bone resorption; calcium; phosphorus; TGF-β; undercarboxylated osteocalcin Citation: Klein, G.L. The Products of Bone Resorption and Their Roles in 1. Introduction Metabolism: Lessons from the Study of Burns. Osteology 2021, 1, 73–79. In recent years we have learned much about the mechanisms of bone formation and https://doi.org/10.3390/ resorption, the cells involved, and many of the factors that affect and link the two processes.
    [Show full text]
  • Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting
    nutrients Article Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting Masaki Nakano, Yukio Nakamura * , Akiko Miyazaki and Jun Takahashi Department of Orthopaedic Surgery, School of Medicine, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan; [email protected] (M.N.); [email protected] (A.M.); [email protected] (J.T.) * Correspondence: [email protected]; Tel.: +81-263-37-2659; Fax: +81-263-35-8844 Abstract: Although there have been reported associations between zinc and bone mineral density (BMD), no reports exist on the effect of zinc treatment in osteoporotic patients. Therefore, we investigated the efficacy and safety of zinc pharmacotherapy in Japanese elderly patients. The present investigation included 122 osteoporotic patients with zinc deficiency, aged ≥65 years, who completed 12 months of follow-up. In addition to standard therapy for osteoporosis in a clinical setting, the subjects received oral administration of 25 mg zinc (NOBELZIN®, an only approved drug for zinc deficiency in Japan) twice a day. BMD and laboratory data including bone turnover markers were collected at 0 (baseline), 6, and 12 months of zinc treatment. Neither serious adverse effects nor incident fractures were seen during the observation period. Serum zinc levels were successfully elevated by zinc administration. BMD increased significantly from baseline at 6 and 12 months of zinc treatment. Percentage changes of serum zinc showed significantly positive associations with those of BMD. Bone formation markers rose markedly from the baseline values, whereas bone Citation: Nakano, M.; Nakamura, Y.; resorption markers displayed moderate or no characteristic changes.
    [Show full text]
  • Is Melatonin the Cornucopia of the 21St Century?
    antioxidants Review Is Melatonin the Cornucopia of the 21st Century? Nadia Ferlazzo, Giulia Andolina, Attilio Cannata, Maria Giovanna Costanzo, Valentina Rizzo, Monica Currò , Riccardo Ientile and Daniela Caccamo * Department of Biomedical Sciences, Dental Sciences, and Morpho-Functional Imaging, Polyclinic Hospital University, Via C. Valeria 1, 98125 Messina, Italy; [email protected] (N.F.); [email protected] (G.A.); [email protected] (A.C.); [email protected] (M.G.C.); [email protected] (V.R.); [email protected] (M.C.); [email protected] (R.I.) * Correspondence: [email protected]; Tel.: +39-090-221-3386 or +39-090-221-3389 Received: 21 September 2020; Accepted: 3 November 2020; Published: 5 November 2020 Abstract: Melatonin, an indoleamine hormone produced and secreted at night by pinealocytes and extra-pineal cells, plays an important role in timing circadian rhythms (24-h internal clock) and regulating the sleep/wake cycle in humans. However, in recent years melatonin has gained much attention mainly because of its demonstrated powerful lipophilic antioxidant and free radical scavenging action. Melatonin has been proven to be twice as active as vitamin E, believed to be the most effective lipophilic antioxidant. Melatonin-induced signal transduction through melatonin receptors promotes the expression of antioxidant enzymes as well as inflammation-related genes. Melatonin also exerts an immunomodulatory action through the stimulation of high-affinity receptors expressed in immunocompetent cells. Here, we reviewed the efficacy, safety and side effects of melatonin supplementation in treating oxidative stress- and/or inflammation-related disorders, such as obesity, cardiovascular diseases, immune disorders, infectious diseases, cancer, neurodegenerative diseases, as well as osteoporosis and infertility.
    [Show full text]
  • Bone and Cartilage Metabolism
    BONE AND CARTILAGE METABOLISM IMMUNOASSAYS Cat. No. Description Assay Format Sample Type Assay Range Sandwich ELISA, RIS021R 1,25(OH)2-Vitamin-D Total ELISA Serum 7.5 – 322.5 pg/ml HRP-labelled antibody Sandwich ELISA, RKARF1991R Free 25-OH Vitamin D ELISA Serum HRP-labelled antibody RIS024R Extraction kit for 1,25(OH)2-Vitamin-D Total ELISA Extraction Cartridges for 1,25(OH)2-Vitamin-D Total RIS023R ELISA Sandwich ELISA, RIS020R 25-OH-Vitamin-D Total ELISA Serum 0 – 180 ng/ml HRP-labelled antibody Competitive ELISA, Serum, Plasma REA300/96 25-OH-Vitamin D ELISA Immobilized antibody (EDTA, citrate, heparin) Sandwich ELISA, RIS022R 25-OH-Vitamin-D Total Rat ELISA Serum 5.3 – 133 ng/ml HRP-labelled antibody Sandwich ELISA, Serum, Synovial fluid 10 – 150 ng/ml RIS001R Aggrecan (PG) Human ELISA HRP-labelled antibody Sandwich ELISA, RIS0019R Calcitonin (CT) Human ELISA, High Sensitivity Serum 10 – 400 pg/ml HRP-labelled antibody Sandwich ELISA, Serum, Plasma RD194080200 Cartilage Oligomeric Matrix Protein Human ELISA 4 – 128 ng/ml Biotin-labelled antibody (EDTA, citrate, heparin) Sandwich ELISA, Serum, Plasma (EDTA, citrate, RD191035200R Connective Tissue Growth Factor Human ELISA Biotin-labelled antibody heparin), Urine 0.63 – 20 ng/ml Sandwich ELISA, RD191207200R Dickkopf-Related Protein 1 Human ELISA Serum Biotin-labelled antibody 0.125 – 4 ng/ml Direct ELISA, RD191124200R ENPP1 Human ELISA Serum, Plasma (citrate) Biotin-labelled antibody 0.25 – 16 ng/ml Sandwich ELISA, Serum, Plasma (EDTA, citrate, RAF013R Erythropoietin Human ELISA Biotin-labelled
    [Show full text]
  • Evaluation of Osteonectin As a Diagnostic Marker of Osteogenic Bone Tumors
    Original Research Article DOI: 10.18231/2456-9267.2018.0019 Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors Murad Ahmad1, Sadaf Mirza2, Kafil Akhtar3,*, Rana K. Sherwani4, Khalid A Sherwani5 1Assistant Professor, 2Resident, 3,4Professor, 1-4Dept. of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim 5 University, Aligarh, Uttar Pradesh, Professor, Dept. of Orthopaedics Surgery, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India *Corresponding Author: Email: [email protected] Abstract Introduction: Immunohistochemistry plays an important but limited role in the diagnosis of primary bone tumors. Sometimes it is very difficult to differentiate osteosarcomas histologically from other tumors with similar morphology but with different malignant potential and treatment protocol. The correct diagnosis of OSA relies on identification of osteoid production by malignant cells which can be detected by the use of osteonectin. Materials and Methods: The present study was carried out on 200 patients of benign and malignant lesions of bone. After a detailed clinical history and local examination, paraffin section of resected specimens were studied by hematoxylin and eosin and immunohistochemical stain, osteonectin and matrix was graded on a four-tiered grading system with statistical analysis of osteonectin positivity in osteogenic bone tumours and tumour-like lesions. Results: Benign and malignant tumours accounted for 74.6% and 25.0% of the total cases. Osteoid production were seen in 36 cases (100.0%) of osteosarcomas, followed by fibrous dysplasia in 18 cases (100.0%) and osteoid osteoma in 10 cases (100.0%). Both polygonal and spindle shaped tumour cells in osteosarcoma showed Grade 4 positivity with osteonectin.
    [Show full text]
  • Leptin Mediated Pathways Stabilize Posttraumatic Insulin And
    International Journal of Molecular Sciences Article Leptin Mediated Pathways Stabilize Posttraumatic Insulin and Osteocalcin Patterns after Long Bone Fracture and Concomitant Traumatic Brain Injury and Thus Influence Fracture Healing in a Combined Murine Trauma Model Anja Garbe 1,*, Frank Graef 1 , Jessika Appelt 1,2 , Katharina Schmidt-Bleek 2 , Denise Jahn 1,2, Tim Lünnemann 1, Serafeim Tsitsilonis 1 and Ricarda Seemann 1 1 Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 13353 Berlin, Germany; [email protected] (F.G.); [email protected] (J.A.); [email protected] (D.J.); [email protected] (T.L.); [email protected] (S.T.); [email protected] (R.S.) 2 Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, 13353 Berlin, Germany; [email protected] * Correspondence: [email protected] Received: 24 October 2020; Accepted: 28 November 2020; Published: 30 November 2020 Abstract: Recent studies on insulin, leptin, osteocalcin (OCN), and bone remodeling have evoked interest in the interdependence of bone formation and energy household. Accordingly, this study attempts to investigate trauma specific hormone changes in a murine trauma model and its influence on fracture healing. Thereunto 120 female wild type (WT) and leptin-deficient mice underwent either long bone fracture (Fx), traumatic brain injury (TBI), combined trauma (Combined), or neither of it and therefore served as controls (C). Blood samples were taken weekly after trauma and analyzed for insulin and OCN concentrations.
    [Show full text]
  • Nutritional Zinc Plays a Pivotal Role in Bone Health and Osteoporosis Prevention
    Edorium J Nutr Diet 2015;1:1–8. Yamaguchi 1 www.edoriumjournals.com/ej/nd EDITORIAL OPEN ACCESS Nutritional zinc plays a pivotal role in bone health and osteoporosis prevention Masayoshi Yamaguchi Bone homeostasis is maintained through a delicate cardiovascular diseases, cancer and diabetesaffecting the balance between osteoblastic bone formation and aging population [6–8]. osteoclastic bone resorption [1, 2]. Bone mass is reduced Osteoporosis has also been shown to induce after by decrease in osteoblastic bone formation and increase diabetes (type I and II), obesity, inflammatory disease, and in osteoclastic bone resorption. Numerous pathological various pathophysiological states. Diabetic osteoporosis processes have the capacity to disrupt this equilibrium is noticed in recent years [7, 8]. Diabetes is frequent leading to conditions where the rate of bone resorption in the elderly, and therefore frequently coexists with outpaces the rate of bone formation. Osteoporosis is osteoporosis. Furthermore, there has also been a global induced with decrease in bone mass. The most dramatic increase in the prevalence of obesity, with obesity-related expression of osteoporosis is represented by fractures of diabetes currently affecting over 366 million adults the proximal femur for which the number increases as worldwide and projections that this will reach 552 million the population ages [3, 4]. Osteoporosis is characterized by 2030 [9]. Type 1 diabetes, and more recently type 2 by reduced bone strength and an increased risk for low- diabetes, has been associated with increased fracture risk. trauma fractures. Bone mass is dramatically reduced In Western societies, mean body weight has dramatically after menopause, which depresses the secretion of increased in older people, and a similar trend exists in ovarian hormone (estrogen) in women [5].
    [Show full text]
  • Gene Expression Profiling of Differentiated Thyroid Neoplasms: Diagnostic and Clinical Implications
    6586 Vol. 10, 6586–6597, October 1, 2004 Clinical Cancer Research Gene Expression Profiling of Differentiated Thyroid Neoplasms: Diagnostic and Clinical Implications Sylvie Chevillard,1 Nicolas Ugolin,1 entiation, adhesion, immune response, and proliferation as- Philippe Vielh,2 Katherine Ory,1 Ce´line Levalois,1 sociated pathways. Quantitative real-time reverse transcrip- Danielle Elliott,4 Gary L. Clayman,3 and tion-PCR analysis of selected genes corroborated the 4 microarray expression results. Adel K. El-Naggar Conclusions: Our study show the following: (1) differ- 1 Laboratoire de Cance´rologie Expe´rimentale, Commissariat a´ ences in gene expression between tumor and nontumor bear- L’Energie Atomique, Direction des Sciences du Vivant, De´partement ing normal thyroid tissue can be identified, (2) a set of genes du Radiobiologie et Radiopathologie, Fontenay-aux-Roses Cedex France; 2De´partement de Pathologie, Institut Gustave Roussy, differentiate follicular neoplasm from follicular variant of Villejuif Cedex, France; Departments of 3Head and Neck Surgery and papillary carcinoma, (3) follicular adenoma and carcinoma 4Pathology, The University of Texas M.D. Anderson Cancer Center, share many of the differentiated genes, and (4) gene expres- Houston, Texas sion differences identify conventional papillary carcinoma from the follicular variant. ABSTRACT Purpose: The purpose of this research was to identify INTRODUCTION novel genes that can be targeted as diagnostic and clinical Differentiated thyroid epithelial tumors represent a spec- markers of differentiated thyroid tumors. trum of morphologically and biologically diverse lesions. The Experimental Design: Gene expression analysis using follicular-derived neoplasms (adenoma, carcinoma, and the fol- microarray platform was performed on 6 pathologically licular variant of papillary carcinoma) manifest overlapping normal thyroid samples and 12 primary follicular and pap- cytomorphologic features and not infrequently pose diagnostic illary thyroid neoplasms.
    [Show full text]